285 related articles for article (PubMed ID: 21917650)
21. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
22. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
23. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
25. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
26. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
27. The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance.
Wang W; Bu XM; Wang J; Zhang N; Zhao CH
Oncol Rep; 2012 Jun; 27(6):1953-9. PubMed ID: 22427032
[TBL] [Abstract][Full Text] [Related]
28. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.
Deng J; Liang H; Dong Q; Hou Y; Xie X; Yu J; Fan D; Hao X
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25008234
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
30. MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.
Wang K; Liang Q; Li X; Tsoi H; Zhang J; Wang H; Go MY; Chiu PW; Ng EK; Sung JJ; Yu J
Gut; 2016 Oct; 65(10):1619-31. PubMed ID: 26206665
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
32. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
[TBL] [Abstract][Full Text] [Related]
33. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.
Cheung KF; Lam CN; Wu K; Ng EK; Chong WW; Cheng AS; To KF; Fan D; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):947-59. PubMed ID: 21717426
[TBL] [Abstract][Full Text] [Related]
35. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
36. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
38. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
39. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
40. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]